Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN)
- Resource Type
- Article
- Source
- In
Contemporary Clinical Trials Communications April 2022 26 - Subject
- Language
- ISSN
- 2451-8654